2015
DOI: 10.1038/ng.3253
|View full text |Cite
|
Sign up to set email alerts
|

Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia

Abstract: Some familial platelet disorders are associated with predisposition to leukemia, myelodysplastic syndrome (MDS) or dyserythropoietic anemia.1,2 We identified a family with autosomal dominant thrombocytopenia, high erythrocyte mean corpuscular volume (MCV) and two occurrences of B-cell precursor acute lymphoblastic leukemia (ALL). Whole exome sequencing identified a heterozygous single nucleotide change in ETV6 (Ets Variant Gene 6), c.641C>T, encoding a p.Pro214Leu substitution in the central domain, segregatin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

12
246
2
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 291 publications
(266 citation statements)
references
References 36 publications
12
246
2
2
Order By: Relevance
“…ETV6 mutations are mostly clustered in the DNA-binding and central domains, which abrogates the ETV6 nuclear localization and results in reduced expression of ETV6 and other platelet-associated genes. 44,45 Germline ETV6 mutations have recently been reported as a rare form of inherited thrombocytopenia with predisposition to hematologic malignancy. 44 44 There is no consistent defect in platelet aggregation or activation; platelet spreading appears reduced on fibrinogen but not on collagen and von Willebrand factor.…”
Section: Myeloid Neoplasms With Germline Etv6 Mutationmentioning
confidence: 99%
See 1 more Smart Citation
“…ETV6 mutations are mostly clustered in the DNA-binding and central domains, which abrogates the ETV6 nuclear localization and results in reduced expression of ETV6 and other platelet-associated genes. 44,45 Germline ETV6 mutations have recently been reported as a rare form of inherited thrombocytopenia with predisposition to hematologic malignancy. 44 44 There is no consistent defect in platelet aggregation or activation; platelet spreading appears reduced on fibrinogen but not on collagen and von Willebrand factor.…”
Section: Myeloid Neoplasms With Germline Etv6 Mutationmentioning
confidence: 99%
“…44,45 Germline ETV6 mutations have recently been reported as a rare form of inherited thrombocytopenia with predisposition to hematologic malignancy. 44 44 There is no consistent defect in platelet aggregation or activation; platelet spreading appears reduced on fibrinogen but not on collagen and von Willebrand factor. 45 Similar to RUNX1-and AKND26-affected pedigrees, ETV6-related thrombocytopenia is also characterized by normal-sized platelets, 44,45 but electric microscopy shows occasional elongated platelet a granules in affected individuals.…”
Section: Myeloid Neoplasms With Germline Etv6 Mutationmentioning
confidence: 99%
“…Mutations in NBEAL2 were determined to be the causative mutation in GPS by next‐generation RNA sequencing of platelets, whole exome sequencing and traditional sequencing strategies, respectively 37, 38, 39. More recently, ETV6 has been implicated in inherited thrombocytopenia using next‐generation sequencing techniques 40, 41…”
Section: Genomic Approaches To Congenital Platelet Disordersmentioning
confidence: 99%
“…In several cancer-predisposing conditions, hematopoietic malignancies are included among a spectrum of other neoplasms that can also develop ( Table 2, including ETV6-and PAX5-related familial acute lymphoblastic leukemia (ALL) [8][9][10][11] ; predispositions to acute myeloid leukemia (AML) as a result of germ line mutations in RUNX1, CEBPA, or GATA2 [12][13][14] ; and disorders associated with development of lymphoma, such as X-linked lymphoproliferative disease type 1. Because of space constraints, we direct the reader to several excellent recent reviews for a more comprehensive discussion of the cancer genetic susceptibility syndromes associated with development of these blood cancers.…”
Section: Genetic Susceptibility Syndromes That Predispose To Hematopomentioning
confidence: 99%